From: MicroRNA genetic signature in non-small cell lung cancer (NSCLC) Egyptian patients
mi RNA | Log (fold change) (mean ± sd) | p value | |
---|---|---|---|
Control | NSCLC patients | ||
miR-15b-5p | 1.32 ± 0.12 | 3.33 ± 0.82 | 0.001* |
miR-193b | − 0.06 ± 0.02 | 0.24 ± 0.04 | 0.001* |
miR-301 | − 0.05 ± 0.03 | 0.15 ± 0.02 | 0.001* |
miR-141 | − 0.16 ± 0.02 | 0.32 ± 0.07 | 0.001* |
miR-200b | − 0.05 ± 0.03 | 0.73 ± 0.11 | 0.001* |
miR-423-5p_st | 2.50 ± 0.30 | 6.41 ± 0.22 | 0.001* |
miR-22 | − 0.06 ± 0.02 | 0.25 ± 0.18 | 0.001* |
miR-19 a | − 0.10 ± 0.12 | 0.25 ± 0.06 | 0.001* |
miR-21 | − 0.16 ± 0.02 | 0.06 ± 0.01 | 0.001* |
miR-210 | 0.55 ± 0.02 | 0.85 ± 0.03 | 0.001* |
miR-340 | 0.12 ± 0.03 | 0.45 ± 0.02 | 0.001* |
miR-203 | 0.05 ± 0.03 | 0.15 ± 0.02 | 0.001* |
miR-221 | 0.12 ± 0.02 | 0.20 ± 0.04 | 0.001* |